MedPath

A Novel Sperm Selection Method Provides Advantages Over Conventional Approaches

Not Applicable
Completed
Conditions
Male Infertility
Interventions
Device: Density Gradient Centrifugation
Device: CA0 chamber
Registration Number
NCT06545318
Lead Sponsor
Center of Innovation Technology & Reproductive Medicine
Brief Summary

The goal of this clinical trial is to know if a novel sperm selection device (CA0) has a similar performance than the standard selection method in teratozoospermic and azoospermic men. The main questions it aims to answer are:

Does the CA0 sperm selection device increases the sperm concentration? Does the CA0 sperm selection device increases the sperm motility? What are the differences in sperm membrane potential when CA0 is used? Do intracellular Calcium levels change when CA0 is used? Does CA0 increase fertilization rates? Researchers will compare CA0 to the standard of care for sperm selection (density gradient centrifugation) to see if CA0 has similar performance

Participants will:

Provide a semen sample Have their semen sample analyzed, processed and used for assisted reproduction technologies

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
115
Inclusion Criteria
  • Normozoospermic (18-35 years old) and teratozoospermic (18-60 years old) patients undergoing IVF/ICSI cyles with at least 2 days of sexual abstinence
Read More
Exclusion Criteria
  • Less than 4 oocytes collected during oocyte retrieval
  • Total sperm count less than 30x10^6
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Density Gradient CentrifugationDensity Gradient CentrifugationA density gradient of is formed in 15 mL conical tubes as follows: 1 mL of lower gradient (90%) medium is placed at the bottom, 1 mL of upper (45%) gradient medium is placed on top of the bottom layer, and 1 mL of semen sample is layered above the gradient. Tubes are centrifuged for 10 minutes at 1,200 x g at room temperature. The pellet containing the viable cells is separated, resuspended in 1 mL of HTF-HEPES medium, and centrifuged at room temperature for 10 minutes at 1,200 x g to remove traces of gradient medium. The supernatant is then removed, 500 µL of HTF-HEPES medium are added to the sperm pellet, carefully mixed, and cells are counted
CA0 chamberCA0 chamberOne mL of semen is placed in the base, then the intermediate part is placed on the base, taking care to match the notches that assemble both parts. Subsequently, 900 µL of HTF-HEPES medium are placed in the intermediate part, the cover is placed and the device is incubated at 37°C for 30 minutes. Subsequently, a 500-µL aliquot is recovered and cells are counted
Primary Outcome Measures
NameTimeMethod
Sperm intracellular CalciumWithin 2 hours from the sperm collection

Evaluation of the progesterone-induced intracellular calcium fluorescent peaks after sperm selection

Sperm motilityWithin 2 hours from the sperm collection

Percentage of progresive, non-progressive and immotile sperm after sperm separation

Sperm concentrationWithin 2 hours from the sperm collection

Assessment of sperm count after sperm separation

Sperm membrane potentialWithin 2 hours from the sperm collection

Evaluation of the KCl-induced difference of membrane potential voltage in mV, after sperm selection.

Fertilization rates17-20 hours after insemination by IVF or ICSI

Determination of the rate of 2 pronucleous, 2 polar bodies zygotes after insemination

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CITMER

🇲🇽

Mexico City, Mexico

© Copyright 2025. All Rights Reserved by MedPath